© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
February 29, 2020
Advanced cystic fibrosis liver disease manifests as portal hypertension with or without cirrhosis in about 7% of patients with cystic fibrosis.
October 31, 2019
In a pioneer study, investigators investigate if cannabis users had less incidence of pancreatic necrosis and/or pancreatic/peripancreatic fluid collections.
October 30, 2019
Roberto Simons-Linares, MD, presents new data at the annual ACG meeting on the association between hepatitis viral infections and acute pancreatitis.
October 29, 2019
During the annual ACG meeting, Roberto Simons-Linares, MD explained how cannabis use impacts the fluids of patients suffering from acute necrotizing pancreatitis.
October 21, 2019
The newly approved drug is a combination of 3 drugs that target the most common cystic fibrosis mutation.
June 21, 2019
The FDA had previously only certified Symdeko tablets for treatment of children aged 12 years and older.
October 15, 2018
Results connecting breathlessness catastrophizing with reduced quality of life also have implications for populations with asthma or COPD.
October 02, 2018
Upon finding pH and oxygen may influence how antibiotics perform in CF lung infections, investigators suggest a one-size-fits-all therapy approach may not be the best treatment.
September 10, 2018
Investigators find telavancin has potent in vitro activity and low resistance development potential when used against S aureus isolates in patients with cystic fibrosis.
August 18, 2018
Stay up-to-date on the latest rare disease news by reading the top 5 articles of the week.